BioPharm International - September 2024

BioPharm International - September 2024

Issue link: https://www.e-digitaleditions.com/i/1526741

Contents of this Issue

Navigation

Page 3 of 31

BioPharm I N T E R N AT I O N A L eBook T h e S ci e n ce & B usi n e ss o f B i o p h a r m a ce u t i c a ls FOUNDER Mike Hennessy Sr 1960 - 2021 © 2024 MultiMedia Pharma Sciences LLC All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/educational or personal use, or the internal/educational or personal use of specific clients is granted by MultiMedia Pharma Sciences LLC for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700 or visit http://www. copyright.com online. For uses beyond those listed above, please direct your written request to BPpress@ mmhgroup.com with "Permissions" in the subject line. Reprints: Contact Brian Haug, Bhaug@mmhgroup.com. MultiMedia Pharma Sciences LLC provides certain customer contact data (such as customers' names, addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want MultiMedia Pharma Sciences LLC to make your contact information available to third parties for marketing purposes, simply email mmhinfo@ mmhgroup.com and a customer service representative will assist you in removing your name from MultiMedia Pharma Sciences LLC lists. BioPharm International ® does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance of such content. BioPharm International welcomes unsolicited articles, manuscripts, photographs, illustrations, and other materials but cannot be held responsible for their safekeeping or return. To subscribe, email mmhinfo@mmhgroup.com Contents EDITORIAL Vice President, Content Alicia Bigica ABigica@mjhlifesciences.com Associate Editorial Director Felicity Thomas FThomas@mjhlifesciences.com Lead Editor Susan Haigney SHaigney@mjhlifesciences.com Science Editor Feliza Mirasol FMirasol@mjhlifesciences.com Editor Patrick Lavery PLavery@mjhlifesciences.com Contributing editors Cynthia A. Challener Design and Production Creative Director Robert McGarr rmcgarr@mjhlifesciences.com Senior Art Director Kristen Morabito kmorabito@mjhlifesciences.com Print and Circulation Director Jonathan Severn jsevern@mjhassoc.com Production Manager Charlton Prince cprince@mjhlifesciences.com Print Production Coordinator Amber Immordino ammordino@mjhassoc.com CUSTOM CONTENT Director Robert Alaburda Managing Editor Jeanne Linke Northrop Senior Editor Megan Manzano Senior Editor Shannon Stolz ADVERTISING National Sales Manager Scott Vail SVail@mjhlifesciences.com Sales Manager Joel Kern JKern@mjhlifesciences.com National Account Associate Padraic Finnegan PFinnegan@mjhlifesciences.com European Sales Manager Linda Hewitt LHewitt@mjhlifesciences.com European Senior Sales Executive Stephen Cleland SCleland@mjhlifesciences.com Director, Industry Relations and Strategic Partnerships Chris Spivey CSpivey@mjhlifesciences.com MJH LIFE SCIENCES ® President & CEO Mike Hennessy Jr Chief Financial Officer Neil Glasser, CPA/CFE Chief Operating Officer Beth Buehler Chief Data Officer Terric Townsend Executive Vice President, Global Medical Affairs & Corporate Development Joe Petroziello Executive Vice President, Healthcare Brian Haug Senior Vice President, Content Silas Inman Senior Vice President, Human Resources & Administration Shari Lundenberg Senior Vice President, Mergers & Acquisitions, Strategic Innovation Phil Talamo Executive Creative Director Jeff Brown Emerging Therapies eBook September 2024 Cover: Anusorn – Stock.Adobe.com CELL AND GENE THERAPIES Frontrunners in Automated Cell and Gene Therapy Manufacturing Cheryl Barton Innovative solutions are making personalized cell and gene therapies accessible to all. 4 CELL LINE DEVELOPMENT Ensuring Cell Line Stability for Protein Therapeutics Roxana McCloskey and Zoe Zhang Stable cell line development can benefit from applying integrated analytical technologies. 8 ANTIBODY-DRUG CONJUGATES Valuing Specialized Experience in ADC Development Pamela James Bringing promising ADC candidates to market faster hinges on the biopharma industry investing in linker design capabilities. 16 DEVELOPMENT The Logistics of Developing an Emerging Therapy Susan Haigney Emerging therapies, such as cell and gene therapies, come with unique challenges that must be planned for in advance. 22 INDUSTRY UPDATE Update on Trends in Emerging Therapies and Manufacturing Patrick Lavery The latest developments in emerging therapies including new innovations and collaborative efforts in manufacturing. 28 AD INDEX 30 www.biopharminternational.com Emerging Therapies eBook September 2024 BioPharm International ® 3

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - September 2024 - BioPharm International - September 2024